Skip to content

Prospective Follow-up, Marathon, Long Term, Inflammation and Cardiovascular System

Prospective Long Term Follow-up Analysis of Exercise-induced Physiological Changes in Male Runners

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04166903
Acronym
Pro-MagIC
Enrollment
277
Registered
2019-11-18
Start date
2019-11-15
Completion date
2021-06-30
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants of the Be-MaGIC-Study 2009

Keywords

Prolonged exercise, marathon, cardiovascular disease, long term

Brief summary

Pro-MagIC is a prospective observational study and includes participants of the Be-MaGIC-Study 2009 (n=277/NCT00933218). We aim to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years.

Detailed description

Physical activity is associated with health benefits. Acute prolonged and strenuous exercise, i.e. Marathon running, leads to hemodynamic, endothelial and myocardial functional changes. Whether these myocardial, endothelial and hemodynamic changes can also develop and persist through repetitive extreme and prolonged physical activity is currently still a matter of controversy. In addition, it is not known whether adaptations and changes over time can develop into clinically relevant cardiovascular events with negative health consequences in healthy athletes. The aim of this study is to detect exercise-induced physiological changes (inter alia of the cardiovascular system) induced by repetitive ultra-endurance strain over a period of 10 years. For this purpose, 277 male participants from the Be-MaGIC study (Marathon 2009) are examined in this prospective observational study. A single examination with the following components will take place: Anthropometry, clinical examination, laboratory, resting / exercise electrocardiography cardiopulmonary stress test, echocardiography, and fundus camera. Further examinations will be conducted in participants with abnormal examination results in line with current clinical recommendations.

Interventions

None listed

Sponsors

Balgrist University Hospital
CollaboratorOTHER
Deutsches Herzzentrum Muenchen
CollaboratorOTHER
Technical University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Declaration of consent Participants must have participated in the Be-MaGIC study in 2009 * current age: 30 - 70 years * sex: male

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Changes of right ventricular systolic function (RV-EF)10 yearsEchocardiography

Secondary

MeasureTime frameDescription
Changes in left ventricular diastolic function (E/e´)10 yearsEchocardiography
Change in cardiac markers (e.g. cardiac Troponin)10 yearsClinical chemistry (blood samples)
Change in inflammation markers (e.g. C-reactive Protein)10 yearsClinical chemistry (blood samples)
Changes in left ventricular ejection fraction (LV-EF)10 yearsEchocardiography
Change in macrocirculation (e.g. Intima media thickness)10 yearsCarotid sonography
Change of prevalence of cardiovascular diseases10 yearsQuestionnaire
Association between changes of aforementioned parameters (see Topics 1-8) and potential underlying causes (e.g. sports history like number of ultraendurance competitions) in the examined cohort10 years
Change in microcirculation (e.g. arteriolar-to-venular ratio)10 yearsStatic Retinal Vessel Analyzer

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026